Logo

Abbott Gets CE Mark for PCR-Based Chlamydia Test

Jan 18, 2008
NEW YORK (GenomeWeb News) – Abbott Laboratories said yesterday that it has received the CE Mark for a PCR-based test that can detect a new variant strain of Chlamydia trachomatis that has been found in one in five chlamydia cases in Sweden.
 
The assay, which may now be sold for clinical diagnostic use throughout the European Union, is run on Abbott’s automated m2000 real-time PCR system. Abbott said that the assay would be offered in Europe as part of its alliance with Celera.
 
Wide incidence of the mutant strain has been limited to Sweden, according to Abbott, but cases also have been reported in Ireland, Norway, Denmark, and France.
 
Abbott also sells PCR-based assays in Europe for HIV-1, hepatitis C virus, and hepatitis C viral load.

Breaking News
The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.